HINGE BIO
Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies. It features chemical ligation process technology that enables the production of therapeutic candidates with orders-of-magnitude improved affinity and specificity. The company was founded in 2015 and headquartered in Burlingame, California.
HINGE BIO
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2015-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.hingebio.com
Total Employee:
1+
Status:
Active
Contact:
650-488-7070
Email Addresses:
[email protected]
Total Funding:
224.46 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Hinge Bio
Official Site Inspections
http://www.hingebio.com
- Host name: 170.0.153.160.host.secureserver.net
- IP address: 160.153.0.170
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Hinge Bio"
About Us – Hinge Bio, Inc.
Dr. Capon is a molecular biologist with extensive experience in biotech invention and innovation. He holds forty-nine United States Patents covering recombinant Factor VIII for the treatment of …See details»
Hinge Bio, Inc. – Taking antibodies to the next dimension
Uniquely enables (i) cooperative binding to disease targets allowing for orders-of-magnitude enhanced activity and (ii) greater degrees of multivalency and multispecificity than possible with conventional approaches, to produce …See details»
Hinge Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 650-488-7070 Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop …See details»
Hinge Bio - LinkedIn
Hinge Bio is honored to have our CSO, Dan Capon, Ph.D., present our GEM-DIMER platform during the “Pioneering Technology” Session at the University of Oxford, Kennedy Institute of Rheumatology ...See details»
Hinge Bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hinge Bio, Inc. of Burlingame, CA. Get the latest business insights from Dun & Bradstreet.See details»
Hinge Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 Learn more at www.hingebio.com. CONTACTS Hinge Bio: Carin Rollins Chief Operating Officer [email protected] or [email protected] . Cell Therapy. 100 Deals …See details»
Technology – Hinge Bio, Inc.
This technology uniquely enables (i) cooperative binding to disease targets allowing for orders-of-magnitude enhanced activity and (ii) greater degrees of multivalency and multispecificity than …See details»
Hinge Bio Information - RocketReach
Hinge Bio, Inc. is leveraging its proprietary Flex-Hinge antibody platform to develop the next-generation of multi-functional antibodies and Fc-fusion proteins that bind targets with multi …See details»
Hinge Bio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Hinge Bio. Use the PitchBook Platform to explore the full profile.See details»
Hinge Bio Raises $30 Million Series A’ Financing to ... - BioSpace
Jan 15, 2025 Learn more at www.hingebio.com. CONTACTS. Hinge Bio: Carin Rollins. Chief Operating Officer . [email protected] or [email protected] . 650.488.7070. Twitter; …See details»
Hinge Bio - Overview, News & Similar companies | ZoomInfo.com
Jan 18, 2023 Hinge Bio contact info: Phone number: (650) 488-7070 Website: www.hingebio.com What does Hinge Bio do? Hinge Bio, Inc. is leveraging its proprietary Flex …See details»
Hinge Bio Expands Senior Management Team to Drive
Jan 18, 2023 Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge...See details»
Hinge Bio Raises $30 Million Series A’ Financing to Develop Next ...
Hinge Bio, Inc. is a privately held development-stage biotechnology company leveraging its proprietary GEM-DIMER™ platform to design and develop therapeutics leading to better …See details»
Hinge Bio - Products, Competitors, Financials, Employees, …
Headquarters Location. 863 Mitten Road Suite 100L. Burlingame, California, 94010, United States. 650-488-7070See details»
Hinge Bio Raises $30 Million Series A’ Financing to Develop Next ...
Jan 15, 2025 Funding will support the development of Company’s lead product candidate for autoimmune disease as well as novel constructs to treat other indications with significant …See details»
Contact Us – Hinge Bio, Inc.
Hinge Bio is always looking for talent with the passion and commitment to bring the next generation of therapeutics to patient care. If you want to be a part of the Hinge Bio team, …See details»
From 'Cockroach Award' to the Big Board: Hinge Health's unlikely …
5 days ago Hinge Health, a 10-year-old digital health company, is poised to kick off its IPO roadshow at a time when fellow upstarts are delaying plans to go public.See details»
Hinge Bio Raises $30 Million Series A’ Financing to Develop
BURLINGAME, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Hinge Bio, Inc., a privately-held biotechnology company, today announced the close of a Series A’ financing led by Point72.See details»
Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development …
BURLINGAME, Calif., May 30, 2023 — Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company ...See details»
Hinge Bio Raises $30 Million Series A’ Financing to Develop Next ...
Jan 15, 2025 [email protected] or [email protected] 650.488.7070. Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. SHARE …See details»